Study of Biochemical Parameters in Major Thalassemia Patients

Mohammed I. Almajidi; Thulfeqar A. Hamza

doi:10.61704/jpr.v24i2.pp54-60

المؤلفون

Mohammed I. Almajidi Department of Chemistry, College of Science for Women, University of Babylon, Babylon, Iraq
Thulfeqar A. Hamza Department of Medical Laboratory Techniques, College of Technology and Health Sciences, Al-Mustaqbal University, Babylon, Iraq

DOI:

https://doi.org/10.61704/jpr.v24i2.pp54-60

الكلمات المفتاحية:

Thalassemia، Alkaline Phosphatase، Hemoglobin، GOT، GPT

الملخص

Thalassemia is a genetic disorder that affects the production of hemoglobin, the protein that carries oxygen in red blood cells. This disorder alters some blood and biochemical parameters, leading to anemia and other complications. We conducted a study on 120 thalassemia patients from the Thalassemia Center at Baghdad Hospital in Iraq, from April 2022 to March 2023. The patients had an average age of 13 ± 3.5 years. We measured their hematological and biochemical parameters and compared them with healthy controls. We found that the patients had lower levels of red blood cells (RBC), hemoglobin (Hb), and packed cell volume (PCV) than the controls, and higher levels of glutamic-oxaloacetic transaminase (GOT), glutamic-pyruvic transaminase (GPT), alkaline phosphatase, and urea. The differences were statistically significant (P < 0.05). Our study shows the impact of thalassemia on blood and biochemical parameters and highlights the need for effective treatment and management of this disorder.

المراجع

Olivieri, N. (1999). The Beta-Thalassemia, New England Journal of Medicine, 341, pp. 99-109.

Najdecki, R., Georgiou, I., and Lolis, D. (1998). The Thalassemia Syndromes and Pregnancy, Molecular Basis, Clinical Aspects, Prenatal Diagnosis, Ginekologia Polska, 69, pp. 664-668.

Weatherall, D. (1965). The Thalassemia Syndromes, Blackwell Scientific Publications.

Borgna-Pignatti, C., Rugolotto, S., De Stefano, P., Zhao, H., Cappellini, M., Del Vecchio, G., Romeo, M., Forni, G., Gamberini, M., Ghilardi, R., Piga, A., and Cnaan, A. (2004). Survival and Complications in Patients with Thalassemia Major Treated with Transfusion and Deferoxamine, Haematologica, 89, pp. 1187-1193.

Vichinsky, E., Butensky, E., Fung, E., Hudes, M., Ferrell, L., Williams, R., Louie, L., Lee, P., Harmatz, P., and Pakbaz, Z. (2005). Comparison of Organ Dysfunction in Transfused Patients with SCD or Beta Thalassemia, American Journal of Hematology, 80, pp. 70-74.

Abd-Ali, M., and Abd-Reza, M. (2019). Clinical Study of β-Thalassemia Major Patients, 11(3), pp. 909-911.

Saltman, P. (1989). Oxidative Stress: A Radical View, Seminars in Hematology, 26, pp. 249-256.

Zurlo, M., De Stefano, P., Borgna-Pignatti, C., Di Palma, A., Piga, A., Melevendi, C., Di Gregorio, F., Burattini, M., and Terzoli, S. (1989). Survival and Causes of Death in Thalassaemia Major, Lancet, 2, pp. 27-30.

Hong, C., Kang, H., Lee, J., Kim, H., Park, J., Shin, H., Ahn, H., and Yoo, K. (2013). Clinical Characteristics of Pediatric Thalassemia in Korea: A Single Institute Experience, Journal of Korean Medical Science, 28, pp. 1645-1649.

Shah, P., Goyal, R., Gosai, M., and Tripathi, C. (2013). Protective Actions of Wheatgrass Capsules in Patients with Thalassemia Major, Pharma Science Monitor, 4, pp. 296-302.

Munir, B., Iqbal, T., Jamil, A., and Muhammad, F. (2013). Effect of β-Thalassemia on Hematological and Biochemical Profiles of Female Patients, Pakistan Journal of Life and Social Sciences, 11(1), pp. 25-28.

Neufeld, E. (2010). Update on Iron Chelators in Thalassemia, Hematology, 2010, 1, pp. 451-455.

Bazvand, F., Shams, S., Borji Esfahani, M., Koochakzadeh, L., Monajemzadeh, M., and Zandieh, F. (2011). Total Antioxidant Status in Patients with Major β-Thalassemia, Iranian Journal of Pediatrics, 21(2), pp. 159-165.